Soft Tissue Sarcomas Pediatric Research and Clinical Trials

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact Dana-Farber/ Boston Children's

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is the New England Phase I Center of the Children's Oncology Group. If your child has progressive or recurrent tumor, she may be eligible for a number of experimental therapies available through these groups, or from one of our independent clinical investigators.

There are many ways in which your child might benefit from our medical research program. Our doctors and scientists have made many breakthrough discoveries about diseases like polio and leukemia; our ongoing innovative research continues to push the boundaries of the way pediatric medicine is practiced.

It’s possible that your child will be eligible to participate in one of our current clinical trials. These studies are useful for a multitude of reasons:

Some trials are designed to evaluate the effectiveness of a particular drug, treatment or therapy on a specific disease; others help doctors to better understand how and why certain conditions occur. At any given time,

We have hundreds of clinical trials underway. Of course, your motives as a parent needn’t be entirely altruistic—you’ll naturally want to know how taking part in a trial can immediately benefit your child. If your child’s physician recommends participation in one of Children’s clinical trials, that likely means that your child’s physician believes that the plan outlined in that trial represents the absolute best, latest care your child can possibly receive.

And participation in any clinical trial is completely voluntary: We will take care to fully explain all elements of the treatment plan prior to the start of the trial, and you may remove your child from the medical study at any time.

Research underway

Our scientists are conducting numerous research studies that will help clinicians better understand and treat soft tissue sarcomas.

Types of treatment currently being studied include:

  • Angiogenesis inhibitors are substances that may be able to prevent the growth of tumors.
  • Biological therapies is a wide range of substances that may be able to involve the body's own immune system to fight cancer or lessen harmful side effects of some treatments

Find a clinical trial

To search for a cancer trial at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, go to

http://www.dana-farber.org/Apps/clinical_trials/search.aspx (under Pediatric).     

To search the NIH’s list of clinical trials taking place around the world, go to:

http://www.clinicaltrials.gov/ct2/search

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close